June 01, 2016 1:34 AM ET

Pharmaceuticals

Company Overview of Johnson & Johnson

Executive Profile

Alastair John Tanton Clemow Ph.D., MBA

Executive Officer, Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 12 different industries.

See Board Relationships
63--

Background

Dr. Alastair John Tanton Clemow, PhD, MBA, serves as the President and Chief Executive Officer of Regentis Biomaterials Ltd. Dr. Clemow serves as an Advisor of Kinetic Muscles, Inc. He has more than 25 years of experience in the development and management of orthopaedic devices and also has over 30 years of senior management experience within healthcare companies. Dr. Clemow served as the President and Chief Executive Officer of Nexgen Spine Inc., from 2004 to 2009. ...

Corporate Headquarters

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships

Director
Advisor and Director
Director
2010-Present
Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

MBA
Columbia University
PhD
University of Surrey
BS
University of Surrey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David S. Taylor Chief Executive Officer, President and Director
The Procter & Gamble Company
$1.7M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$5.2M
Severin Schwan Ph.D.Chief Executive Officer and Executive Director
Roche Holding AG
$7.1M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Johnson & Johnson, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.